Importance: The US Preventive Services Task Force recommends that individuals at high risk for lung cancer consider benefits and harms before pursuing lung cancer screening. Medical centers develop websites for their lung cancer screening programs, but to date little is known about the websites' portrayal of benefits and harms or what next steps they recommend for individuals considering screening. Objective: To assess the presentation of potential benefits and harms and recommended next steps on lung cancer screening program websites. Design, Setting, and Participants: Cross-sectional content analysis of 162 lung cancer screening program websites of academic medical centers (n = 81) and state-matched community medical centers (n = 81) that were randomly selected from American College of Radiology lung cancer screening-designated centers was conducted. The study was performed from December 1, 2018, to January 31, 2019. Main Outcomes and Measures: Website presentation of screening-associated benefits and harms was the primary outcome. Benefit was defined as any description related to the potential reduction in lung cancer mortality. Harms were based on the US Preventive Services Task Force recommendations and included false positives, false negatives, overdiagnosis, radiation exposure, and incidental findings. The secondary outcome was next steps that are recommended by websites. Results: Overall, the 162 lung cancer screening program websites described the potential benefits more frequently than they described any potential harms (159 [98%] vs 78 [48%], P
CITATION STYLE
Clark, S. D., Reuland, D. S., Enyioha, C., & Jonas, D. E. (2020). Assessment of Lung Cancer Screening Program Websites. In JAMA Internal Medicine (Vol. 180, pp. 824–830). American Medical Association. https://doi.org/10.1001/jamainternmed.2020.0111
Mendeley helps you to discover research relevant for your work.